Abstract
The understanding and management of lymphomas have evolved significantly over the past decade. Among the most important changes have been the development of new classification systems that include molecular determinants, identification of etiologic factors for mucosa-associated lymphomas (and their implications for management), demonstration of the importance of T cells in the progression of B-cell lymphomas, development of an international tumor scoring system to better determine prognosis, and establishment of bone marrow transplant as effective therapy in relapsed non-Hodgkin’s lymphoma. This chapter explores these issues and their implications for the practicing oncologist.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84: 1361–1392, 1994.
The Non-Hodgkin’s Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of Non-Hodgkin’s lymphomas. Summary and description of a Working Formulation for clinical usage. Cancer 49: 2112–2135, 1982.
Longo DL. The REAL classification of lymphoid neoplasms: One clinician’s view. Principles Pract Oncol Update 9: 1–12, 1995.
The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 329: 987–994, 1993.
Löpez-Guillermo A, Montserrat E, Bosch F, Terol M, Campo E, Rozman C. Applicability of the international index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol 12: 1343–1348, 1994.
Rodriguez J, Cabanillas F, McLaughlin P, Swan F, Rodriguez M, Hagemeister F, Romaguera J. A proposal for a simple staging system for intermediate grade lymphoma and immuno-blastic lymphoma based on the ‘tumor score.’ Ann Oncol 3: 711–717, 1992.
Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue: A distinctive type of B-cell lymphoma. Cancer 52: 1410–1416, 1983.
Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1: 1273–1275, 1983.
Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: Factors relevant to prognosis. Gastroenterology 102: 1628–1638, 1992.
Roggero E, Zucca E, Pinotti G, Pascarella A, Capella C, Savio A, Pedrinis E, Paterlini A, Venco A, Cavalli F. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 122: 767–769, 1995.
Bayerdörffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M, for the MALT Lymphoma Study Group. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 345: 1591–1594, 1995.
Cammarota G, Montalto M, Tursi A, Vecchio FM, Fedeli G, Gasbarrini G. Helicobacter pylori reinfection and rapid relapse of low-grade B-cell gastric lymphoma. Lancet 345: 192, 1995.
Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke R, Jellum E, Orentreich N, Vogelman JH, Friedman GD. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330: 1267–1271, 1994.
Isaacson PG. Gastric lymphoma and Helicobacter pylori. N Engl J Med 330: 1310–1311, 1994.
Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342: 571–574, 1993.
Azuma T, Konishi J, Tanaka Y, Hirai M, Ito S, Kato T, Kohli Y. Contribution of HLA-DQA gene to host’s response against Helicobacter pylori. Lancet 343: 542–543, 1994.
Yahanda A, Mansfield P. The role of locoregional therapy in the treatment of stage IE and HE gastric lymphoma (abstr). Proceedings of the Society of Surgical Oncology, 47th Annual Cancer Symposium, 1994, p. 19.
Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, Mason D, Pileri S, Ralfkiaer E, Stein H, Warnke RA. Mantle cell lymphoma: A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 16: 637–640, 1992.
Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM. A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): A Southwest Oncology Group study. Blood 85: 1075–1082, 1995.
Stewart DA, Vose JM, Weisenburger DD, Anderson JR, Ruby El, Bast MA, Bierman PJ, Kessinger A, Armitage JO. The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma. Ann Oncol 6: 263–266, 1995.
Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA, Miller TP. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Engl J Med 328: 1002–1006, 1993.
Velasquez WS, Cabanillas F, Salvador P, McLaughlin P, Fridrik M, Tucker S, Jagannath S, Hagemeister FB, Redman JR, Swan F, Barlogie B. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose ara-C and dexamethasone (DHAP). Blood 71: 117–122, 1988.
Philip T, Guglielmi C, Hagenbeek A, Somers R, Van Der Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn J-Y, Harousseau J-L, Coiffier B, Biron P, Mandelli F, Chauvin F. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma. N Engl J Med 333: 1540–1545, 1995.
Vose JM. Treatment for non-Hodgkin’s lymphoma in relapse. N Engl J Med 333: 1565–1566, 1995.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mansfield, P.F., Hunt, K.K. (1997). Classification, staging, and management of non-Hodgkin’s lymphomas. In: Pollock, R.E. (eds) Surgical Oncology. Cancer Treatment and Research, vol 90. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6165-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6165-1_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7826-6
Online ISBN: 978-1-4615-6165-1
eBook Packages: Springer Book Archive